Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity SONIC HEALTHCARE LIMITED

ABN

24 004 196 909

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director

Colin Stephen Goldschmidt

Date of last notice

26 November 2019

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest

Direct

Nature of indirect interest

Nil

(including registered holder)

Note: Provide details of the circumstances giving

rise to the relevant interest.

Date of change

7 September 2020, 8 September 2020, 10 September 2020

and 11 September 2020

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

No. of securities held prior to change

Direct

741,230 Sonic Healthcare Limited ordinary shares

255,008 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2015, expiring 20 November

2020; exercisable at $19.41 each under the Sonic Healthcare

Limited Employee Option Plan having satisfied performance

criteria

164,559 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2016, expiring 17 November

2021; exercisable at $21.62 each under the Sonic

Healthcare Limited Employee Option Plan having satisfied

performance criteria

467,467 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2017 and will vest on 22

November 2020, subject to performance criteria over

period 1 July 2017 to 30 June 2020; exercisable at $21.64

each under the Sonic Healthcare Limited Employee Option

Plan

60,766 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2017 and will vest on 22

November 2020 subject to performance criteria over

period 1 July 2017 to 30 June 2020, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

462,372 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2018 and will vest on 21

November 2021, subject to performance criteria over

period 1 July 2018 to 30 June 2021; exercisable at $21.69

each under the Sonic Healthcare Limited Employee Option

Plan

60,626 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2018 and will vest on 21

November 2021, subject to performance criteria over

period 1 July 2018 to 30 June 2021, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

407,747 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2019 and will vest on 19

November 2022, subject to performance criteria over

period 1 July 2019 to 30 June 2022; exercisable at $29.26

each under the Sonic Healthcare Limited Employee Option

Plan

44,941 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2019 and will vest on 19

November 2022, subject to performance criteria over

period 1 July 2019 to 30 June 2022, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Class

Fully paid ordinary shares in Sonic Healthcare Limited

Number acquired

255,008 Sonic Healthcare Limited ordinary shares acquired

from the exercise of options.

Number disposed

250,000 ordinary shares in Sonic Healthcare Limited.

Value/Consideration

255,008 ordinary shares acquired on payment of

Note: If consideration is non‐cash, provide details

$4,949,705.28 to exercise options.

and estimated valuation

$32.373 per share on the sale of ordinary shares.

  • See chapter 19 for defined terms. 01/01/2011 Appendix 3Y Page 3

Appendix 3Y

Change of Director's Interest Notice

No. of securities held after change

Direct

746,238 Sonic Healthcare Limited ordinary shares

164,559 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2016, expiring 17 November

2021; exercisable at $21.62 each under the Sonic

Healthcare Limited Employee Option Plan having satisfied

performance criteria

467,467 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2017 and will vest on 22

November 2020, subject to performance criteria over

period 1 July 2017 to 30 June 2020; exercisable at $21.64

each under the Sonic Healthcare Limited Employee Option

Plan

60,766 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2017 and will vest on 22

November 2020 subject to performance criteria over

period 1 July 2017 to 30 June 2020, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

462,372 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2018 and will vest on 21

November 2021, subject to performance criteria over

period 1 July 2018 to 30 June 2021; exercisable at $21.69

each under the Sonic Healthcare Limited Employee Option

Plan

60,626 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2018 and will vest on 21

November 2021, subject to performance criteria over

period 1 July 2018 to 30 June 2021, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

407,747 unlisted options over ordinary shares in Sonic

Healthcare Limited, issued in 2019 and will vest on 19

November 2022, subject to performance criteria over

period 1 July 2019 to 30 June 2022; exercisable at $29.26

each under the Sonic Healthcare Limited Employee Option

Plan

44,941 unlisted performance rights over ordinary shares in

Sonic Healthcare Limited, issued in 2019 and will vest on 19

November 2022, subject to performance criteria over

period 1 July 2019 to 30 June 2022, with Nil exercise price

under the Sonic Healthcare Limited Performance Rights Plan

+ See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original document
  • Permalink

Disclaimer

Sonic Healthcare Limited published this content on 14 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 September 2020 07:34:05 UTC